Melanoma-associated antigen C2 (MAGEC2) IVD, antibody
One or multiple immunoglobulins capable of binding to specific antigenic determinants and intended to be used for the qualitative and/or quantitative detection of melanoma-associated antigen C2 (MAGEC2) in a clinical specimen.